Researchers at VCU Massey Cancer Center identified a novel, protein-based combination therapy through which tumor resistance can be overcome to more effectively treat colorectal cancer.
New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one’s biological age, which can be higher than his or her chronological age – a concept called accelerated aging – may predict who’s at risk for developing colon polyps, a known risk factor for colorectal cancer.
